Nix Patterson has been named the 2019 Trial Team of the Year by The National Trial Lawyers in recognition of the firm’s $465 million verdict against opioid manufacturer Johnson & Johnson. Nix Patterson, along with co-counsel Whitten Burrage, represented the State of Oklahoma in its historic litigation against the manufacturers of addictive opioid pain medications.
News Practice Area: Dangerous Drug and Medical Device Litigation
Nix Patterson & Whitten Burrage Begin Historic Trial in Oklahoma Opioid Litigation
See Law360 Article below: “Meet The Attorneys Facing Off In The Oklahoma Opioid Trial” Please note: After publication of this article, the Teva Defendants entered into a settlement agreement with the State of Oklahoma for $85 Million.
Nix Patterson and Whitten Burrage Obtain Historic $270 Million Settlement with Purdue Pharma in Oklahoma Opioid Litigation
On March 26, 2019, the State of Oklahoma announced that one of the defendants in litigation against several manufacturers of opioid-based painkillers, Purdue Pharma, had agreed to pay $270 million to settle the claims brought against it by the State of Oklahoma and Oklahoma Attorney General Mike Hunter. The State alleged Purdue aggressively marketed its
Oklahoma Supreme Court Rejects Big Pharma’s Request to Delay Trial in Oklahoma Opioid Litigation
On March 25, 2019, the Oklahoma Supreme Court denied a request by Defendant drugmakers to delay the start of the first state lawsuit against opioid manufacturers to go to trial. Cleveland County District Court Judge Thad Balkman previously rejected the delay request, saying the matter is of huge public importance and should move forward in
Oklahoma Attorney General Says Defendant in Oklahoma Opioid Litigation, Johnson & Johnson, Acted as Opioid “Kingpin”
In a February 26th filing in Cleveland County District Court, Oklahoma Attorney General Mike Hunter alleged that Johnson & Johnson acted as an opioid “kingpin” by using a web of foreign and domestic subsidiaries to supply raw materials “necessary to manufacture the opioid pain medications thrust upon the unsuspecting public since the 1990s.” In the
NP and Whitten Burrage Win Motion to Remand in Oklahoma Opioid Litigation
As previously reported, NP and co-counsel, Whitten Burrage, represent the State of Oklahoma and Oklahoma Attorney General Mike Hunter in litigation against several manufacturers of opioid pain killers in a lawsuit filed in Cleveland County, Oklahoma, entitled State of Oklahoma v. Purdue Pharma, L.P., et al. On June 13, 2018, the Purdue defendants filed a
NPR and Whitten Burrage File Lawsuit Against Opioid Manufacturers on Behalf of the Chickasaw and Choctaw Nations
On August 2, 2018, NPR and co-counsel Whitten Burrage filed lawsuits on behalf of the Chickasaw and Choctaw Nations against several large pharmaceutical companies that manufacture highly addictive and often deadly opioid painkillers—including Purdue Pharma, Johnson & Johnson, Janssen, and Cephalon. The lawsuits, filed in Pontotoc County, Oklahoma and Bryan County, Oklahoma, respectively, allege the
NPR & Whitten Burrage Defeat Motions to Dismiss in Oklahoma Opioid Litigation
As previously reported, NPR and co-counsel, Whitten Burrage, represent the State of Oklahoma and Oklahoma Attorney General Mike Hunter in litigation against several manufacturers of opioid based pain killers in a lawsuit filed in Cleveland County, Oklahoma, entitled State of Oklahoma v. Purdue Pharma, L.P., et al. The defendant drug manufacturers filed motions to dismiss all
NPR & Whitten Burrage Defeat Defendants’ Motion for Protective Order Staying Discovery in Oklahoma Opioid Litigation
As previously reported, NPR and co-counsel, Whitten Burrage, represent the State of Oklahoma and Oklahoma Attorney General Mike Hunter in litigation against several manufacturers of opioid-based painkillers in a lawsuit filed in Cleveland County, Oklahoma, entitled State of Oklahoma v. Purdue Pharma, L.P., et al. On September 15, 2017, the defendant drug manufacturers filed a Motion
GranuFlo Claims Submission Process Closes
The claims submission process for all qualifying GranuFlo and NaturaLyte claims on file against Fresenius Medical Care officially ended on November 10, 2017. The Settlement Administrator, Epiq, continues processing all claims submitted by counsel for Plaintiffs. Epiq anticipates the claims will be processed sometime in January 2018. Upon determination by Epiq as to whether a